flash-heat treatment of expressed breastmilk

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly increased folate and vitamin B12 concentrations in breastmilk from HIV-positive mothers, and ascorbic acid increased with borderline significance, likely due to heat

Effect: improvement; 1.44; CI: 95% CI 1.23 to 1.69

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99